D-0724-2021 Class II Ongoing
FDA drug recall D-0724-2021 was initiated by Noven Pharmaceuticals Inc on Jul 30, 2021 and is designated Class II. Reason for recall: Failed Stability Specifications; out of specification for shear. The recall status is ongoing. Affected quantity: 223,382 boxes.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 25, 2021
- Initiation Date
- Jul 30, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 223,382 boxes
Product description
Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.14 mg per day, 50/140 Twice Weekly, Rx Only a) 2 Systems NDC 68968-0514-2 b) 8 Systems NDC 68968-0514-8, Mfd. by: Noven Pharmaceuticals, Inc., Miami, Florida 33186, Dist. by: Noven Therapeutics LLC, Miami, Florida 33186
Reason for recall
Failed Stability Specifications; out of specification for shear.
Distribution pattern
Nationwide.
Code information
Lots: 88542 Exp. 03/2022; 88227 Exp. 12/2021; 88696 Exp. 05/2022; 89357 Exp. 08/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0724-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026